{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:04:27Z","timestamp":1788980667061,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060180"],"award-info":[{"award-number":["82060180"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11033-023-08692-y","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T16:00:36Z","timestamp":1691164836000},"page":"8653-8663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["NAD+ metabolism and eye diseases: current status and future directions"],"prefix":"10.1007","volume":"50","author":[{"given":"Siyuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"issue":"1","key":"8692_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","volume":"5","author":"N Xie","year":"2020","unstructured":"Xie N, Zhang L, Gao W (2020) NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target therapy 5(1):227","journal-title":"Signal Transduct Target therapy"},{"issue":"3","key":"8692_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/ars.2017.7216","volume":"28","author":"W Xiao","year":"2018","unstructured":"Xiao W, Wang RS, Handy DE (2018) NAD(H) and NADP(H) redox couples and Cellular Energy Metabolism. Antioxid Redox Signal 28(3):251\u2013272","journal-title":"Antioxid Redox Signal"},{"key":"8692_CR3","doi-asserted-by":"publisher","first-page":"154923","DOI":"10.1016\/j.metabol.2021.154923","volume":"126","author":"X Chu","year":"2022","unstructured":"Chu X, Raju RP (2022) Regulation of NAD(+) metabolism in aging and disease. Metab Clin Exp 126:154923","journal-title":"Metab Clin Exp"},{"issue":"6326","key":"8692_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE (2017) Vitamin B(3) modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Sci (New York NY) 355(6326):756\u2013760","journal-title":"Sci (New York NY)"},{"issue":"9","key":"8692_CR5","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/ng.2356","volume":"44","author":"RK Koenekoop","year":"2012","unstructured":"Koenekoop RK, Wang H, Majewski J (2012) Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration. Nat Genet 44(9):1035\u20131039","journal-title":"Nat Genet"},{"key":"8692_CR6","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Pardo I, Villarejo-Zori B, Jim\u00e9nez-Loygorri JI (2022) Ambra1 haploinsufficiency in CD1 mice results in metabolic alterations and exacerbates age-associated retinal degeneration. Autophagy :1\u201321","DOI":"10.1101\/2022.02.04.476630"},{"issue":"22","key":"8692_CR7","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1111\/j.1742-4658.2011.08366.x","volume":"278","author":"N Braidy","year":"2011","unstructured":"Braidy N, Guillemin GJ, Mansour H (2011) Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats. FEBS J 278(22):4425\u20134434","journal-title":"FEBS J"},{"issue":"2","key":"8692_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1210\/er.2009-0026","volume":"31","author":"RH Houtkooper","year":"2010","unstructured":"Houtkooper RH, Cant\u00f3 C, Wanders RJ (2010) The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31(2):194\u2013223","journal-title":"Endocr Rev"},{"key":"8692_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2147\/OPTH.S80784","volume":"9","author":"S Kaja","year":"2015","unstructured":"Kaja S, Shah AA, Haji SA (2015) Nampt\/PBEF\/visfatin serum levels: a new biomarker for retinal blood vessel occlusions. Clin Ophthalmol (Auckland NZ) 9:611\u2013618","journal-title":"Clin Ophthalmol (Auckland NZ)"},{"issue":"1","key":"8692_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.celrep.2016.08.073","volume":"17","author":"JB Lin","year":"2016","unstructured":"Lin JB, Kubota S, Ban N (2016) NAMPT-Mediated NAD(+) biosynthesis is essential for Vision in mice. Cell Rep 17(1):69\u201385","journal-title":"Cell Rep"},{"issue":"6","key":"8692_CR11","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.18632\/aging.101469","volume":"10","author":"RN Jadeja","year":"2018","unstructured":"Jadeja RN, Powell FL, Jones MA (2018) Loss of NAMPT in aging retinal pigment epithelium reduces NAD(+) availability and promotes cellular senescence. Aging 10(6):1306\u20131323","journal-title":"Aging"},{"key":"8692_CR12","doi-asserted-by":"publisher","first-page":"970553","DOI":"10.3389\/fphar.2022.970553","volume":"13","author":"Y Wei","year":"2022","unstructured":"Wei Y, Xiang H, Zhang W (2022) Review of various NAMPT inhibitors for the treatment of cancer. Front Pharmacol 13:970553","journal-title":"Front Pharmacol"},{"issue":"12","key":"8692_CR13","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1158\/1535-7163.MCT-18-0643","volume":"17","author":"CS Neumann","year":"2018","unstructured":"Neumann CS, Olivas KC, Anderson ME (2018) Targeted delivery of cytotoxic NAMPT inhibitors using antibody-drug conjugates. Mol Cancer Ther 17(12):2633\u20132642","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"8692_CR14","doi-asserted-by":"publisher","first-page":"e21456","DOI":"10.1096\/fj.202001826R","volume":"35","author":"R Zapata-P\u00e9rez","year":"2021","unstructured":"Zapata-P\u00e9rez R, Tammaro A, Schomakers BV (2021) Reduced nicotinamide mononucleotide is a new and potent NAD(+) precursor in mammalian cells and mice. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(4):e21456","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"issue":"7","key":"8692_CR15","doi-asserted-by":"publisher","first-page":"e13943","DOI":"10.15252\/emmm.202113943","volume":"13","author":"R Zapata-P\u00e9rez","year":"2021","unstructured":"Zapata-P\u00e9rez R, Wanders RJA, van Karnebeek CDM (2021) NAD(+) homeostasis in human health and disease. EMBO Mol Med 13(7):e13943","journal-title":"EMBO Mol Med"},{"issue":"5","key":"8692_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10930-017-9734-x","volume":"36","author":"SR Abdelraheim","year":"2017","unstructured":"Abdelraheim SR, Spiller DG, McLennan AG (2017) Mouse Nudt13 is a mitochondrial nudix hydrolase with NAD(P)H pyrophosphohydrolase activity. Protein J 36(5):425\u2013432","journal-title":"Protein J"},{"issue":"9","key":"8692_CR17","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tibs.2021.01.014","volume":"46","author":"N Pandey","year":"2021","unstructured":"Pandey N, Black BE (2021) Rapid Detection and Signaling of DNA damage by PARP-1. Trends Biochem Sci 46(9):744\u2013757","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"8692_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/BST20180419","volume":"47","author":"R Fliegert","year":"2019","unstructured":"Fliegert R, Heeren J, Koch-Nolte F (2019) Adenine nucleotides as paracrine mediators and intracellular second messengers in immunity and inflammation. Biochem Soc Trans 47(1):329\u2013337","journal-title":"Biochem Soc Trans"},{"key":"8692_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.neubiorev.2020.04.013","volume":"115","author":"S Tolomeo","year":"2020","unstructured":"Tolomeo S, Chiao B, Lei Z (2020) A novel role of CD38 and oxytocin as Tandem Molecular moderators of human Social Behavior. Neurosci Biobehav Rev 115:251\u2013272","journal-title":"Neurosci Biobehav Rev"},{"issue":"11","key":"8692_CR20","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s42255-020-00298-z","volume":"2","author":"CCS Chini","year":"2020","unstructured":"Chini CCS, Peclat TR, Warner GM (2020) CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD(+) and NMN levels. Nat metabolism 2(11):1284\u20131304","journal-title":"Nat metabolism"},{"issue":"6233","key":"8692_CR21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1258366","volume":"348","author":"J Gerdts","year":"2015","unstructured":"Gerdts J, Brace EJ, Sasaki Y (2015) SARM1 activation triggers axon degeneration locally via NAD+ destruction. Sci (New York NY) 348(6233):453\u2013457","journal-title":"Sci (New York NY)"},{"key":"8692_CR22","doi-asserted-by":"publisher","first-page":"958900","DOI":"10.3389\/fncel.2022.958900","volume":"16","author":"TJ Waller","year":"2022","unstructured":"Waller TJ, Collins CA (2022) Multifaceted roles of SARM1 in axon degeneration and signaling. Front Cell Neurosci 16:958900","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"8692_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH (2022) The sirtuin family in health and disease. Signal Transduct Target therapy 7(1):402","journal-title":"Signal Transduct Target therapy"},{"issue":"7","key":"8692_CR24","first-page":"632","volume":"43","author":"KH Jang","year":"2020","unstructured":"Jang KH, Hwang Y, Kim E (2020) PARP1 impedes SIRT1-Mediated autophagy during degeneration of the retinal pigment epithelium under oxidative stress. Mol Cells 43(7):632\u2013644","journal-title":"Mol Cells"},{"key":"8692_CR25","doi-asserted-by":"publisher","first-page":"109058","DOI":"10.1016\/j.exer.2022.109058","volume":"219","author":"G Chen","year":"2022","unstructured":"Chen G, Yan F, Wei W (2022) CD38 deficiency protects the retina from ischaemia\/reperfusion injury partly via suppression of TLR4\/MyD88\/NF-\u03baB signalling. Exp Eye Res 219:109058","journal-title":"Exp Eye Res"},{"key":"8692_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.preteyeres.2018.06.002","volume":"67","author":"JB Lin","year":"2018","unstructured":"Lin JB, Apte RS (2018) NAD(+) and sirtuins in retinal degenerative diseases: a look at future therapies. Prog Retin Eye Res 67:118\u2013129","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"8692_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/ng.2361","volume":"44","author":"MJ Falk","year":"2012","unstructured":"Falk MJ, Zhang Q, Nakamaru-Ogiso E (2012) NMNAT1 mutations cause Leber congenital amaurosis. Nat Genet 44(9):1040\u20131045","journal-title":"Nat Genet"},{"issue":"1","key":"8692_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.gene.2015.05.038","volume":"569","author":"Y Deng","year":"2015","unstructured":"Deng Y, Huang H, Wang Y (2015) A novel missense NMNAT1 mutation identified in a consanguineous family with Leber congenital amaurosis by targeted next generation sequencing. Gene 569(1):104\u2013108","journal-title":"Gene"},{"issue":"7","key":"8692_CR29","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.ajpath.2016.03.013","volume":"186","author":"SH Greenwald","year":"2016","unstructured":"Greenwald SH, Charette JR, Staniszewska M (2016) Mouse models of NMNAT1-Leber congenital amaurosis (LCA9) recapitulate key features of the Human Disease. Am J Pathol 186(7):1925\u20131938","journal-title":"Am J Pathol"},{"issue":"28","key":"8692_CR30","doi-asserted-by":"publisher","first-page":"17228","DOI":"10.1074\/jbc.M115.637850","volume":"290","author":"Y Sasaki","year":"2015","unstructured":"Sasaki Y, Margolin Z, Borgo B (2015) Characterization of Leber congenital amaurosis-associated NMNAT1 mutants. J Biol Chem 290(28):17228\u201317238","journal-title":"J Biol Chem"},{"issue":"9","key":"8692_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41419-018-0907-0","volume":"9","author":"H Kuribayashi","year":"2018","unstructured":"Kuribayashi H, Baba Y, Iwagawa T (2018) Roles of Nmnat1 in the survival of retinal progenitors through the regulation of pro-apoptotic gene expression via histone acetylation. Cell Death Dis 9(9):891","journal-title":"Cell Death Dis"},{"issue":"8","key":"8692_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/hmg\/ddab070","volume":"30","author":"SH Greenwald","year":"2021","unstructured":"Greenwald SH, Brown EE, Scandura MJ (2021) Mutant Nmnat1 leads to a retina-specific decrease of NAD + accompanied by increased poly(ADP-ribose) in a mouse model of NMNAT1-associated retinal degeneration. Hum Mol Genet 30(8):644\u2013657","journal-title":"Hum Mol Genet"},{"key":"8692_CR33","doi-asserted-by":"crossref","unstructured":"Sasaki Y, Kakita H, Kubota S (2020) SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration. eLife 9","DOI":"10.7554\/eLife.62027"},{"key":"8692_CR34","doi-asserted-by":"crossref","unstructured":"Ozaki E, Gibbons L, Neto NG (2020) SARM1 deficiency promotes rod and cone photoreceptor cell survival in a model of retinal degeneration. Life Sci alliance 3(5)","DOI":"10.26508\/lsa.201900618"},{"issue":"9","key":"8692_CR35","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/hmg\/ddab324","volume":"31","author":"EE Brown","year":"2022","unstructured":"Brown EE, Scandura MJ, Mehrotra S (2022) Reduced nuclear NAD + drives DNA damage and subsequent immune activation in the retina. Hum Mol Genet 31(9):1370\u20131388","journal-title":"Hum Mol Genet"},{"key":"8692_CR36","doi-asserted-by":"crossref","unstructured":"Sokolov D, Sechrest ER, Wang Y (2021) Nuclear NAD(+)-biosynthetic enzyme NMNAT1 facilitates development and early survival of retinal neurons. eLife. 10","DOI":"10.7554\/eLife.71185"},{"key":"8692_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.omtm.2020.07.003","volume":"18","author":"SH Greenwald","year":"2020","unstructured":"Greenwald SH, Brown EE, Scandura MJ (2020) Gene Therapy preserves retinal structure and function in a mouse model of NMNAT1-Associated Retinal Degeneration. Mol therapy Methods Clin Dev 18:582\u2013594","journal-title":"Mol therapy Methods Clin Dev"},{"key":"8692_CR38","doi-asserted-by":"crossref","unstructured":"Fuller-Carter PI, Basiri H, Harvey AR (2020) Focused update on AAV-Based gene therapy clinical trials for inherited retinal degeneration. BioDrugs: clinical immunotherapeutics, biopharmaceuticals and gene therapy. 34(6):763\u2013781","DOI":"10.1007\/s40259-020-00453-8"},{"issue":"3","key":"8692_CR39","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.exer.2005.08.006","volume":"82","author":"N Uehara","year":"2006","unstructured":"Uehara N, Miki K, Tsukamoto R (2006) Nicotinamide blocks N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in rats through poly (ADP-ribose) polymerase activity and Jun N-terminal kinase\/activator protein-1 pathway inhibition. Exp Eye Res 82(3):488\u2013495","journal-title":"Exp Eye Res"},{"issue":"5","key":"8692_CR40","doi-asserted-by":"publisher","first-page":"e1234","DOI":"10.1038\/cddis.2014.208","volume":"5","author":"A Sahaboglu","year":"2014","unstructured":"Sahaboglu A, Tanimoto N, Bolz S (2014) Knockout of PARG110 confers resistance to cGMP-induced toxicity in mammalian photoreceptors. Cell Death Dis 5(5):e1234","journal-title":"Cell Death Dis"},{"issue":"1","key":"8692_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.12-10861","volume":"54","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Zhang L, Sasaki Y (2013) Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1. Investig Ophthalmol Vis Sci 54(1):25\u201336","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8692_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1146\/annurev-neuro-060909-153248","volume":"33","author":"MP Coleman","year":"2010","unstructured":"Coleman MP, Freeman MR (2010) Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci 33:245\u2013267","journal-title":"Annu Rev Neurosci"},{"issue":"5686","key":"8692_CR43","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1098014","volume":"305","author":"T Araki","year":"2004","unstructured":"Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Sci (New York NY) 305(5686):1010\u20131013","journal-title":"Sci (New York NY)"},{"issue":"8","key":"8692_CR44","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/NEN.0b013e3181afecfa","volume":"68","author":"Y Kitaoka","year":"2009","unstructured":"Kitaoka Y, Hayashi Y, Kumai T (2009) Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy. J Neuropathol Exp Neurol 68(8):915\u2013927","journal-title":"J Neuropathol Exp Neurol"},{"issue":"17","key":"8692_CR45","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1523\/JNEUROSCI.5469-08.2009","volume":"29","author":"Y Sasaki","year":"2009","unstructured":"Sasaki Y, Vohra BP, Lund FE (2009) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J neuroscience: official J Soc Neurosci 29(17):5525\u20135535","journal-title":"J neuroscience: official J Soc Neurosci"},{"issue":"7","key":"8692_CR46","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.neuron.2021.02.009","volume":"109","author":"MD Figley","year":"2021","unstructured":"Figley MD, Gu W, Nanson JD (2021) SARM1 is a metabolic sensor activated by an increased NMN\/NAD(+) ratio to trigger axon degeneration. Neuron 109(7):1118\u201336e11","journal-title":"Neuron"},{"key":"8692_CR47","doi-asserted-by":"crossref","unstructured":"Finnegan LK, Chadderton N, Kenna PF (2022) SARM1 ablation is protective and preserves spatial vision in an in vivo mouse model of retinal ganglion cell degeneration. Int J Mol Sci 23(3)","DOI":"10.3390\/ijms23031606"},{"key":"8692_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnins.2017.00232","volume":"11","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE (2017) Nicotinamide and WLD(S) Act together to prevent neurodegeneration in Glaucoma. Front NeuroSci 11:232","journal-title":"Front NeuroSci"},{"issue":"4","key":"8692_CR49","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ymthe.2022.01.035","volume":"30","author":"F Fang","year":"2022","unstructured":"Fang F, Zhuang P, Feng X (2022) NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function. Mol therapy: J Am Soc Gene Therapy 30(4):1421\u20131431","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"issue":"1","key":"8692_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40478-023-01513-0","volume":"11","author":"JR Tribble","year":"2023","unstructured":"Tribble JR, Hagstr\u00f6m A, Jusseaume K (2023) NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve. Acta Neuropathol Commun 11(1):18","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"8692_CR51","doi-asserted-by":"publisher","first-page":"ar4","DOI":"10.1091\/mbc.E22-03-0078","volume":"34","author":"H Kuribayashi","year":"2023","unstructured":"Kuribayashi H, Katahira M, Aihara M (2023) Loss-of-function approach using mouse retinal explants showed pivotal roles of Nmnat2 in early and middle stages of retinal development. Mol Biol Cell 34(1):ar4","journal-title":"Mol Biol Cell"},{"issue":"7","key":"8692_CR52","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1167\/iovs.19-27099","volume":"60","author":"J Kouassi Nzoughet","year":"2019","unstructured":"Kouassi Nzoughet J, de la Chao JM, Guehlouz K (2019) Nicotinamide Deficiency in Primary Open-Angle Glaucoma. Investig Ophthalmol Vis Sci 60(7):2509\u20132514","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8692_CR53","doi-asserted-by":"crossref","unstructured":"Taechameekietichai T, Chansangpetch S, Peerawaranun P (2021) Association between daily niacin intake and Glaucoma: National Health and Nutrition Examination Survey. Nutrients 13(12)","DOI":"10.3390\/nu13124263"},{"issue":"4\u20135","key":"8692_CR54","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.neuint.2007.09.012","volume":"52","author":"D Ji","year":"2008","unstructured":"Ji D, Li GY, Osborne NN (2008) Nicotinamide attenuates retinal ischemia and light insults to neurones. Neurochem Int 52(4\u20135):786\u2013798","journal-title":"Neurochem Int"},{"key":"8692_CR55","doi-asserted-by":"crossref","unstructured":"Chou TH, Romano GL, Amato R (2020) Nicotinamide-Rich Diet in DBA\/2J Mice Preserves Retinal Ganglion Cell Metabolic Function as Assessed by PERG Adaptation to Flicker. Nutrients 12(7)","DOI":"10.3390\/nu12071910"},{"issue":"7","key":"8692_CR56","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F, Tang J, Williams PA (2020) Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol 48(7):903\u2013914","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"8692_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","volume":"140","author":"CG De Moraes","year":"2022","unstructured":"De Moraes CG, John SWM, Williams PA (2022) Nicotinamide and pyruvate for Neuroenhancement in Open-Angle Glaucoma: a phase 2 Randomized Clinical Trial. JAMA Ophthalmol 140(1):11\u201318","journal-title":"JAMA Ophthalmol"},{"key":"8692_CR58","doi-asserted-by":"crossref","unstructured":"Lee D, Tomita Y, Miwa Y (2022) Nicotinamide Mononucleotide prevents retinal dysfunction in a mouse model of Retinal Ischemia\/Reperfusion Injury. Int J Mol Sci 23(19).","DOI":"10.3390\/ijms231911228"},{"issue":"12","key":"8692_CR59","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.celrep.2015.02.060","volume":"10","author":"J Gilley","year":"2015","unstructured":"Gilley J, Orsomando G, Nascimento-Ferreira I (2015) Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Rep 10(12):1974\u20131981","journal-title":"Cell Rep"},{"key":"8692_CR60","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhang N, Chrenek MA (2021) Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage. Pharmaceutics 13(6)","DOI":"10.3390\/pharmaceutics13060893"},{"issue":"1","key":"8692_CR61","doi-asserted-by":"publisher","first-page":"e2526","DOI":"10.1038\/cddis.2016.437","volume":"8","author":"KH Jang","year":"2017","unstructured":"Jang KH, Do YJ, Son D (2017) AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. Cell Death Dis 8(1):e2526","journal-title":"Cell Death Dis"},{"issue":"10","key":"8692_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1167\/iovs.61.10.47","volume":"61","author":"X Zhang","year":"2020","unstructured":"Zhang X, Henneman NF, Girardot PE (2020) Systemic treatment with Nicotinamide Riboside is protective in a mouse model of Light-Induced Retinal Degeneration. Investig Ophthalmol Vis Sci 61(10):47","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"8692_CR63","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/s41598-020-59244-4","volume":"10","author":"M Zhang","year":"2020","unstructured":"Zhang M, Jiang N, Chu Y (2020) Dysregulated metabolic pathways in age-related macular degeneration. Sci Rep 10(1):2464","journal-title":"Sci Rep"},{"issue":"1","key":"8692_CR64","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12967-016-1101-8","volume":"14","author":"N Golestaneh","year":"2016","unstructured":"Golestaneh N, Chu Y, Cheng SK (2016) Repressed SIRT1\/PGC-1\u03b1 pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. J translational Med 14(1):344","journal-title":"J translational Med"},{"issue":"5","key":"8692_CR65","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stem.2016.12.015","volume":"20","author":"JS Saini","year":"2017","unstructured":"Saini JS, Corneo B, Miller JD (2017) Nicotinamide ameliorates Disease Phenotypes in a human iPSC model of age-related Macular Degeneration. Cell Stem Cell 20(5):635\u201347e7","journal-title":"Cell Stem Cell"},{"key":"8692_CR66","doi-asserted-by":"publisher","first-page":"26322","DOI":"10.1038\/srep26322","volume":"6","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhao KK, Tong Y (2016) Exogenous NAD(+) decreases oxidative stress and protects H2O2-treated RPE cells against necrotic death through the up-regulation of autophagy. Sci Rep 6:26322","journal-title":"Sci Rep"},{"key":"8692_CR67","doi-asserted-by":"crossref","unstructured":"Ren C, Hu C, Wu Y (2022) Nicotinamide Mononucleotide Ameliorates Cellular Senescence and Inflammation Caused by Sodium Iodate in RPE. Oxidative medicine and cellular longevity 2022:5961123","DOI":"10.1155\/2022\/5961123"},{"issue":"4","key":"8692_CR68","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.stemcr.2020.03.009","volume":"14","author":"NC Boles","year":"2020","unstructured":"Boles NC, Fernandes M, Swigut T (2020) Epigenomic and transcriptomic changes during human RPE EMT in a stem cell model of Epiretinal membrane Pathogenesis and Prevention by Nicotinamide. Stem cell reports 14(4):631\u2013647","journal-title":"Stem cell reports"},{"key":"8692_CR69","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.exer.2018.10.009","volume":"179","author":"RA Hazim","year":"2019","unstructured":"Hazim RA, Volland S, Yen A (2019) Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide. Exp Eye Res 179:18\u201324","journal-title":"Exp Eye Res"},{"issue":"1","key":"8692_CR70","first-page":"55","volume":"14","author":"IG Obrosova","year":"2004","unstructured":"Obrosova IG, Minchenko AG, Frank RN (2004) Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression. Int J Mol Med 14(1):55\u201364","journal-title":"Int J Mol Med"},{"issue":"1","key":"8692_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/IAE.0b013e318256202e","volume":"33","author":"S Choudhuri","year":"2013","unstructured":"Choudhuri S, Mandal LK, Paine SK (2013) Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy. Retina (Philadelphia Pa) 33(1):207\u2013216","journal-title":"Retina (Philadelphia Pa)"},{"issue":"9","key":"8692_CR72","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1007\/s00125-011-2226-1","volume":"54","author":"SS Zhu","year":"2011","unstructured":"Zhu SS, Ren Y, Zhang M (2011) Wld(S) protects against peripheral neuropathy and retinopathy in an experimental model of diabetes in mice. Diabetologia 54(9):2440\u20132450","journal-title":"Diabetologia"},{"key":"8692_CR73","doi-asserted-by":"crossref","unstructured":"Zhou RM, Shen Y, Yao J (2016) Nmnat 1: a Security Guard of Retinal Ganglion Cells (RGCs) in Response to High Glucose Stress. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 38(6):2207-18","DOI":"10.1159\/000445576"},{"key":"8692_CR74","doi-asserted-by":"publisher","first-page":"154402","DOI":"10.1016\/j.metabol.2020.154402","volume":"114","author":"Y Li","year":"2021","unstructured":"Li Y, Li J, Zhao C (2021) Hyperglycemia-reduced NAD(+) biosynthesis impairs corneal epithelial wound healing in diabetic mice. Metab Clin Exp 114:154402","journal-title":"Metab Clin Exp"},{"key":"8692_CR75","doi-asserted-by":"publisher","first-page":"112659","DOI":"10.1016\/j.biopha.2022.112659","volume":"147","author":"Q Pu","year":"2022","unstructured":"Pu Q, Guo XX, Hu JJ (2022) Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1\/Nrf2\/HO-1 pathway. Biomed pharmacotherapy = Biomedecine pharmacotherapie 147:112659","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"issue":"10","key":"8692_CR76","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1167\/iovs.19-26909","volume":"60","author":"Y Li","year":"2019","unstructured":"Li Y, Ma X, Li J (2019) Corneal denervation causes epithelial apoptosis through inhibiting NAD + biosynthesis. Investig Ophthalmol Vis Sci 60(10):3538\u20133546","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8692_CR77","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2147\/JIR.S292764","volume":"14","author":"YF Meng","year":"2021","unstructured":"Meng YF, Pu Q, Dai SY (2021) Nicotinamide Mononucleotide alleviates Hyperosmolarity-Induced IL-17a Secretion and Macrophage activation in corneal epithelial Cells\/Macrophage co-culture system. J Inflamm Res 14:479\u2013493","journal-title":"J Inflamm Res"},{"issue":"1","key":"8692_CR78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1167\/iovs.63.1.38","volume":"63","author":"MV Hamity","year":"2022","unstructured":"Hamity MV, Kolker SJ, Hegarty DM (2022) Nicotinamide Riboside alleviates corneal and somatic Hypersensitivity Induced by Paclitaxel in male rats. Investig Ophthalmol Vis Sci 63(1):38","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"8692_CR79","doi-asserted-by":"publisher","first-page":"C796","DOI":"10.1152\/ajpcell.00445.2019","volume":"318","author":"C Zhao","year":"2020","unstructured":"Zhao C, Li W, Duan H (2020) NAD(+) precursors protect corneal endothelial cells from UVB-induced apoptosis. Am J Physiol Cell Physiol 318(4):C796\u2013c805","journal-title":"Am J Physiol Cell Physiol"},{"key":"8692_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.exer.2019.04.012","volume":"184","author":"Z Li","year":"2019","unstructured":"Li Z, Duan H, Li W (2019) Nicotinamide inhibits corneal endothelial mesenchymal transition and accelerates wound healing. Exp Eye Res 184:227\u2013233","journal-title":"Exp Eye Res"},{"key":"8692_CR81","doi-asserted-by":"crossref","unstructured":"Li Z, Duan H, Jia Y (2022) Long-term corneal recovery by simultaneous delivery of hPSC-derived corneal endothelial precursors and nicotinamide. J Clin Investig 132(1)","DOI":"10.1172\/JCI146658"},{"issue":"3","key":"8692_CR82","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1046\/j.1471-4159.2003.01707.x","volume":"85","author":"MA Satchell","year":"2003","unstructured":"Satchell MA, Zhang X, Kochanek PM (2003) A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD + depletion and ribosylation of 14-3-3gamma. J Neurochem 85(3):697\u2013708","journal-title":"J Neurochem"},{"key":"8692_CR83","doi-asserted-by":"publisher","first-page":"111545","DOI":"10.1016\/j.mad.2021.111545","volume":"198","author":"C Li","year":"2021","unstructured":"Li C, Wu LE (2021) Risks and rewards of targeting NAD(+) homeostasis in the brain. Mech Ageing Dev 198:111545","journal-title":"Mech Ageing Dev"},{"key":"8692_CR84","doi-asserted-by":"crossref","unstructured":"Takasawa S (2022) CD38-Cyclic ADP-Ribose Signal System in Physiology, Biochemistry, and pathophysiology. Int J Mol Sci 23(8)","DOI":"10.3390\/ijms23084306"},{"key":"8692_CR85","doi-asserted-by":"crossref","unstructured":"Higashida H, Hashii M, Tanaka Y (2019) CD38, CD157, and RAGE as Molecular Determinants for Social Behavior. Cells 9(1)","DOI":"10.3390\/cells9010062"},{"issue":"2","key":"8692_CR86","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bbrc.2003.10.143","volume":"312","author":"J Takahashi","year":"2003","unstructured":"Takahashi J, Kagaya Y, Kato I (2003) Deficit of CD38\/cyclic ADP-ribose is differentially compensated in hearts by gender. Biochem Biophys Res Commun 312(2):434\u2013440","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"8692_CR87","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1083\/jcb.201008050","volume":"193","author":"CY Chen","year":"2011","unstructured":"Chen CY, Lin CW, Chang CY (2011) Sarm1, a negative regulator of innate immunity, interacts with syndecan-2 and regulates neuronal morphology. J Cell Biol 193(4):769\u2013784","journal-title":"J Cell Biol"},{"key":"8692_CR88","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fncel.2014.00087","volume":"8","author":"CW Lin","year":"2014","unstructured":"Lin CW, Chen CY, Cheng SJ (2014) Sarm1 deficiency impairs synaptic function and leads to behavioral deficits, which can be ameliorated by an mGluR allosteric modulator. Front Cell Neurosci 8:87","journal-title":"Front Cell Neurosci"},{"issue":"7","key":"8692_CR89","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41419-022-05083-2","volume":"13","author":"L Xiang","year":"2022","unstructured":"Xiang L, Wu Q, Sun H (2022) SARM1 deletion in parvalbumin neurons is associated with autism-like behaviors in mice. Cell Death Dis 13(7):638","journal-title":"Cell Death Dis"},{"issue":"47","key":"8692_CR90","doi-asserted-by":"publisher","first-page":"45099","DOI":"10.1074\/jbc.M205670200","volume":"277","author":"KJ Bitterman","year":"2002","unstructured":"Bitterman KJ, Anderson RM, Cohen HY (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277(47):45099\u201345107","journal-title":"J Biol Chem"},{"issue":"18","key":"8692_CR91","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1007\/s00018-017-2527-8","volume":"74","author":"ES Hwang","year":"2017","unstructured":"Hwang ES, Song SB (2017) Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol Life Sci 74(18):3347\u20133362","journal-title":"Cell Mol Life Sci"},{"key":"8692_CR92","doi-asserted-by":"crossref","unstructured":"Canto C (2022) NAD(+) Precursors: A Questionable Redundancy. Metabolites 12(7)","DOI":"10.3390\/metabo12070630"},{"issue":"11","key":"8692_CR93","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s001250051536","volume":"43","author":"M Knip","year":"2000","unstructured":"Knip M, Douek IF, Moore WP (2000) Safety of high-dose nicotinamide: a review. Diabetologia 43(11):1337\u20131345","journal-title":"Diabetologia"},{"issue":"5","key":"8692_CR94","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/cdd.2014.164","volume":"22","author":"M Di Stefano","year":"2015","unstructured":"Di Stefano M, Nascimento-Ferreira I, Orsomando G (2015) A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ 22(5):731\u2013742","journal-title":"Cell Death Differ"},{"key":"8692_CR95","doi-asserted-by":"publisher","first-page":"113842","DOI":"10.1016\/j.expneurol.2021.113842","volume":"345","author":"Y Sasaki","year":"2021","unstructured":"Sasaki Y, Zhu J, Shi Y (2021) Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection. Exp Neurol 345:113842","journal-title":"Exp Neurol"},{"key":"8692_CR96","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.1038\/ncomms12948","volume":"7","author":"SA Trammell","year":"2016","unstructured":"Trammell SA, Schmidt MS, Weidemann BJ (2016) Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun 7:12948","journal-title":"Nat Commun"},{"issue":"1","key":"8692_CR97","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13063-021-05968-1","volume":"23","author":"CKS Leung","year":"2022","unstructured":"Leung CKS, Ren ST, Chan PPM (2022) Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial. Trials 23(1):45","journal-title":"Trials"},{"issue":"1","key":"8692_CR98","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens CR, Denman BA, Mazzo MR (2018) Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults. Nat Commun 9(1):1286","journal-title":"Nat Commun"},{"key":"8692_CR99","doi-asserted-by":"crossref","unstructured":"Sharma C, Donu D, Cen Y (2022) Emerging Role of Nicotinamide Riboside in Health and Diseases. Nutrients 14(19)","DOI":"10.3390\/nu14193889"},{"key":"8692_CR100","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molmet.2019.09.013","volume":"30","author":"J Giroud-Gerbetant","year":"2019","unstructured":"Giroud-Gerbetant J, Joffraud M, Giner MP (2019) A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor. Mol metabolism 30:192\u2013202","journal-title":"Mol metabolism"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08692-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:28:01Z","timestamp":1695695281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08692-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["8692"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08692-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}